COVID-19 Updates

NSPMP COVID 19 Bulletin  October 2020 (PDF Download, 215KB)

Health Canada Exemption  October 1, 2020 (PDF Download, 154KB)

NSPMP COVID 19 Bulletin –  March 2020 (PDF Download, 376KB)

Health Canada Exemption –  March 19, 2020 (PDF Download, 437KB)

 

 

May 2020 Bulletin 

Download File

 Important Information for Pharmacists and Pharmacy Teams:

  • The Nova Scotia generic HCN should not be used

 

 


 NSPMP Announcement: Benzodiazepine Integration

As part of the 2017-2020 Strategic Plan, the NSPMP will begin to integrate benzodiazepine data as part of our monitoring activities on Saturday, October 20th (12:01am).

 

Important information for prescribers and pharmacies:

  • Benzodiazepine prescribers who are not currently registered with NSPMP will need to complete a registration form to obtain an NSPMP ID by October 20th to avoid having their prescriptions held at the pharmacy.
  • Benzodiazepines prescriptions will continue to be written on regular prescription pads (duplicate pads are not required)
  • Benzodiazepine prescribing histories will be available via NSPMP’s e-Access portal on October 20th 

For more information, please review our October 4th 2018 Media Release and the benzodiazepine information outlined in our Frequently Asked Questions document. 

 

 

*NEW*: Re-Order Duplicate Prescription Pads Online

Prescribers who are currently registered with the NSPMP can now re-order duplicate pads via email (PMP@medavie.bluecross.ca) or fax: 902-481-3157. Once received, your order will be delivered via courier within three business days.

CLICK HERE to submit your order via email.

*Effective October 10, 2019, the duplicate pads will be manufactured differently.
(
The content/layout has not changed)

E-Prescribing is available through the DIS Portal

NSPMP allows for e-Prescribing of monitored drugs though the DIS.
More information on e-Prescribing is available here